RecruitingEndometrial Carcinoma
Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding
Eligible age
55+ yrs
Accepts
Women
Locations
3 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study evaluates if AI can be used with transvaginal ultrasound images for early detection of endometrial cancer or premalignant lesions.
Sponsor: Mayo Clinic
You may qualify if…
- ✓ Age ≥ 55 years
- ✓ At least one episode of postmenopausal bleeding (PMB)
- ✓ Endometrial biopsy available from at Mayo Clinic (MN, AZ, FL), Mayo Clinic Health System (MCHS), or an external institution
- ✓ Acceptance to participate in the study
You may not qualify if…
- ✕ Diagnostic tests performed more than 90 days apart
- ✕ Physical impediment/refusal to undergo transvaginal ultrasound (TVUS)
Where it's recruiting
Source: ClinicalTrials.gov · NCT06365905 · last updated 2026-06-10